Overview
Oxygen is an element displayed by the symbol O, and atomic number 8. It is an essential element for human survival. Decreased oxygen levels may be treated with medical oxygen therapy. Treatment with oxygen serves to increase blood oxygen levels and also exerts a secondary effect of decreasing blood flow resistance in the diseased lung, leading to decreased cardiovascular workload in an attempt to oxygenate the lungs. Oxygen therapy is used to treat emphysema, pneumonia, some heart disorders (congestive heart failure), some disorders that cause increased pulmonary artery pressure, and any disease that impairs the body's ability to take up and use gaseous oxygen. Higher level of oxygen than ambient air (hyperoxia) can be introduced under normobaric or hyperbaric conditions.
Indication
Oxygen therapy in clinical settings is used across diverse specialties, including various types of anoxia, hypoxia or dyspnea and any other disease states and conditions that reduce the efficiency of gas exchange and oxygen consumption such as respiratory illnesses, trauma, poisonings and drug overdoses. Oxygen therapy tries to achieve hyperoxia to reduce the extent of hypoxia-induced tissue damage and malfunction.
Associated Conditions
- Anemia
- Cancer
- Hypoxemia
- Hypoxia
- Migraine
- Polycythemia
- Pulmonary Hypertension (PH)
- Respiratory Disorders
- Sleep Apnea
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2019/12/13 | Phase 4 | UNKNOWN | University of Modena and Reggio Emilia | ||
2019/12/10 | Phase 3 | Completed | |||
2019/12/05 | N/A | UNKNOWN | |||
2019/11/04 | Phase 2 | Withdrawn | Norwegian Underwater Intervention (NUI) | ||
2019/10/21 | Phase 4 | UNKNOWN | |||
2019/09/13 | Phase 2 | Withdrawn | |||
2019/08/02 | Phase 3 | UNKNOWN | |||
2019/07/01 | Phase 3 | Completed | Ministry of Health, Spain | ||
2019/05/28 | Early Phase 1 | Recruiting | Omar Aljitawi | ||
2019/03/18 | Phase 3 | Completed |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Health Complex Medical Inc | 64712-001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 3/18/2011 | |
| iMedEquip LLC dba Independent Medical Equipment | 69128-001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 10/4/2023 | |
| Verio Healthcare, Inc. | 72662-123 | RESPIRATORY (INHALATION) | 99 L in 100 L | 12/27/2023 | |
| Billings Clinic Home Oxygen & Medical Equipment Inc | 64866-123 | RESPIRATORY (INHALATION) | 99 L in 100 L | 10/18/2023 | |
| Morgan Medical Equipment & Supply | 52084-0001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 3/15/2010 | |
| Metro Welding Supply Corporation | 62273-007 | RESPIRATORY (INHALATION) | 200 mL in 1 L | 10/18/2023 | |
| North Central Respiratory, Inc | 42887-001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 12/12/2018 | |
| Great Lakes Home Healthcare Services | 64454-0001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 12/15/2009 | |
| Comanche County Hospital Authority DBA Lawton Medi-Equip | 82869-001 | RESPIRATORY (INHALATION) | 99 L in 100 L | 10/25/2023 | |
| Landmark Healthcare, Inc. | 29149-001 | RESPIRATORY (INHALATION) | 990 mL in 1 L | 10/10/2023 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Oxygen | 国药准字H20234343 | 化学药品 | 液态 | 10/24/2023 | |
| Oxygen | 国药准字H20233092 | 化学药品 | 液态 | 1/20/2023 | |
| Oxygen | 国药准字H20233056 | 化学药品 | 液态 | 1/17/2023 | |
| Oxygen | 国药准字H20233091 | 化学药品 | 液态 | 1/20/2023 | |
| Oxygen | 国药准字H20233100 | 化学药品 | 液态 | 1/29/2023 | |
| Oxygen | 国药准字H20243462 | 化学药品 | 液态 | 4/7/2024 | |
| Oxygen | 国药准字H20173262 | 化学药品 | 液态 | 6/13/2022 | |
| Oxygen | 国药准字H20103312 | 化学药品 | 医用气体 | 8/12/2020 | |
| Oxygen | 国药准字H20233197 | 化学药品 | 液态 | 2/14/2023 | |
| Oxygen | 国药准字H20143320 | 化学药品 | 液态气体 | 11/25/2019 |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.